Stoke Therapeutics, Inc. (FRA:0GT)
Germany · Delayed Price · Currency is EUR 24.60
+0.40 (1.65%)
Last updated: Jan 28, 2026, 8:02 AM CET
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of €1.46 billion as of January 30, 2026. Its market cap has increased by 198.57% in one year.
Market Cap
1.46B
Enterprise Value
1.19B
Revenue
175.26M
Ranking
n/a
PE Ratio
42.19
Stock Price
€24.60
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from 717.17M to 1.46B, an increase of 103.38%. That is a compound annual growth rate of 11.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.46B | -5.53% |
| Dec 31, 2025 | 1.54B | 173.62% |
| Dec 31, 2024 | 564.30M | 165.56% |
| Dec 29, 2023 | 212.49M | -37.60% |
| Dec 30, 2022 | 340.54M | -56.12% |
| Dec 31, 2021 | 776.08M | -57.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |